The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent - ScienceDirect

Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease - ScienceDirect

Hepatic deletion of Mboat7 (LPIAT1) causes activation of SREBP-1c and fatty liver - ScienceDirect

Art 3 Non-Alcoholic Fatty Liver Disease A, PDF, Hepatitis

The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent - ScienceDirect

Established and emerging factors affecting the progression of nonalcoholic fatty liver disease - ScienceDirect

The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.

Human hepatocyte PNPLA3-148M exacerbates rapid non-alcoholic fatty liver disease development in chimeric mice - ScienceDirect

Understanding the underlying molecular pathways by which Mboat7/Lpiat1 depletion induces hepatic steatosis - Journal of Lipid Research

Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease